Chancellor Merkel is critical of the release of the patents for corona vaccines.
According to a report, the large manufacturer Biontech is now taking this step.
Mainz -
A political debate is raging about patent protection for corona vaccines.
According to a report, Biontech now wants to temporarily refrain from enforcing patent protection for its vaccine.
As the
Frankfurter Allgemeine Sonntagszeitung
previously reported, according to a spokeswoman, the Mainz company will not take legal action against any imitators until the end of the pandemic.
The US pharmaceutical company Moderna made the same promise a few months ago, according to the report.
Patents for corona vaccines: WHO and Biden for suspension - Merkel against
The corona vaccines from Biontech and its US partner Pfizer as well as from Moderna are based on the new mRNA technology and have so far shown the highest effectiveness of all approved corona vaccines.
The World Health Organization (WHO) is in favor of generally suspending patent protection in order to be able to supply the population of poorer countries with cheap vaccines.
The US government agreed to this demand, Chancellor Angela Merkel (CDU) spoke out against it, and the proposal met with skepticism at the EU summit in Porto.
(AFP / frs) * Merkur.de is an offer from IPPEN.MEDIA